Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-010120
Filing Date
2023-03-28
Accepted
2023-03-28 08:00:24
Documents
4
Period of Report
2023-03-28

Document Format Files

Seq Description Document Type Size
1 6-K sln_6-k_march_updates_3.htm 6-K 41087
2 EX-99.1 sln-ex99_1.htm EX-99 22371
3 EX-99.2 sln-ex99_2.htm EX-99 17022
4 GRAPHIC img248120592_0.jpg GRAPHIC 4687
  Complete submission text file 0000950170-23-010120.txt   88034
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-39487 | Film No.: 23766218
SIC: 2834 Pharmaceutical Preparations